2019
NOV 25, 2019
Renovia Announces FDA 510(k) Clearance of Next-Generation leva® Pelvic Digital Therapeutic
OCT 23, 2019
Solas BioVentures Co-Founder David Adair, M.D. Joins Mayfield Pharmaceuticals Board of Directors
AUG 7, 2019
Renovia Study Results Published in Neurourology and UrodynamicsShow Positive Results for leva® Pelvic Digital Therapeutic in Treating Female Urinary Incontinence
MAY 16, 2019
Transomic CRISPR Library to be Implemented at the Victorian Centre for Functional Genomics
APR 22, 2019
AEGEA Medical Completes Enrollment in PACE MX, the Third Study Assessing Long-Term Access to the Uterine Cavity after Endometrial Ablation with Water Vapor
APR 9, 2019
David Adair, Managing Director of Solas BioVentures, Joins Panel on De-risking Medtech Innovation at SEMDA 2019 Conference
APR 3, 2019
Breakthrough Innovation: The HAART Aortic Annuloplasty Device Cleared by the FDA (BioStable S&E)
APR 2, 2019
Eight Teams in CO.LAB's Inaugural “HealthTech Accelerator” Unveiled at Chattanooga Event (PreTel)
MAR 28, 2019
Renovia Inc. Nominated for MedTech Company of the Year at the New England Venture Capital Association’s 2019 NEVYs Awards
MAR 19, 2019
St. Louis Medical Device Startup Elira Inc. Raises Over $900K in Debt Offering
FEB 22, 2019
Procedure in Indiana Provides Important New Option for Heart Valve Repair (BioStable S&E)
JAN 8, 2019